Clinical Trials

30 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07532746 2026-04-16

A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological Malignancies

55 enrolled

Recurrence, Hematologic Neoplasms

NCT06681363 2026-04-15

LANA

1,000 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07008027 2026-04-15

Real World Asparaginase Therapy Toxicity

200 enrolled

Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT07192237 2026-04-15

Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia

40 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07522905 2026-04-15

Virtual Buddy Movement Therapy for Psychomotor and Social Development in Pediatric Oncology Patients in Remission

40 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07529223 2026-04-14

ASTRA

20 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07313592 2026-04-13

Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients

60 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT07469046 2026-04-13

VAH vs VA in Newly Diagnosed Elderly AML

308 enrolled

Leukemia, Myeloid, Acute

NCT07469592 2026-04-13

eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation

LymphoidMyeloidOther hematologic neoplasm

165 enrolled

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07526597 2026-04-13

STOP-CLL-DCT

45 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07392970 2026-04-09

Motixafortide for MRD Sensitization in AML

10 enrolled

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT07518940 2026-04-09

ENERGIA

MyeloidOther hematologic neoplasm

25 enrolled

Motor Activity, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Primary Myelofibrosis

NCT07521124 2026-04-09

ABC-Maint

104 enrolled

Leukemia, Myeloid, Acute

NCT07516353 2026-04-08

my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults

CNSLymphoidOther hematologic neoplasmSarcoma

143 enrolled

Medulloblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07518654 2026-04-08

ThINKK-01

CNSLymphoidOther hematologic neoplasm

12 enrolled

Paroxysmal nonkinesigenic dyskinesia, Leukemia, Neoplasm Metastasis, Neuroblastoma, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07254793 2026-04-07

Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

LymphoidMyeloidOther hematologic neoplasm

94 enrolled

Lymphoma, Non-Hodgkin, Motor Activity, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07511062 2026-04-06

Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML

32 enrolled

Leukemia, Myeloid, Acute

NCT07374029 2026-04-03

Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML

30 enrolled

Leukemia, Myeloid, Acute

NCT07508995 2026-04-03

A Phase 2 Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In Combination With BCL-2 Inhibitor Sonrotoclax For Patients With Treatment-Naive Chronic Lymphocytic Leukemia (CLL)

40 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07509385 2026-04-03

The Role of Serum Cytokines IL_17 A and IL_10 in Disease Activity of Acute B Lymphoblastic Leukemia in South Egypt

80 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07221656 2026-04-02

Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration

20 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07507825 2026-04-02

VHAG

61 enrolled

Leukemia, Myeloid, Acute

NCT07505160 2026-04-01

Efficacy and Safety of Lisafotoclax Plus Decitabine and Homoharringtonine in Venetoclax/Azacitidine Pretreated AML Patients

35 enrolled

Leukemia, Myeloid, Acute

NCT07495631 2026-03-27

Pediatric-Inspired Regimen Combined With Venetoclax and Immunotherapy for Adult Ph-Negative Acute Lymphoblastic Leukemia

80 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07407140 2026-03-25

VAG-3+7-G

300 enrolled

Leukemia, Myeloid, Acute

NCT05969821 2026-03-23

CHIS

LymphoidMyeloidOther hematologic neoplasm

5,000 enrolled

VEXAS syndrome, Autoimmune Diseases, Hematologic Diseases, Immune System Diseases, Inflammation, Leukemia, Lymphoma, Lymphoproliferative Disorders, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases

NCT06739447 2026-03-23

Hospital Based Continuous Patient Monitoring System

250 enrolled

Wounds and Injuries, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07292272 2026-03-23

Halt Aging in Survivors of Blood Cancers: the HALTAging-1 Study

LymphoidOther hematologic neoplasmPlasma cell

180 enrolled

Hodgkin Disease, Leukemia, Leukemia, Lymphoid, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT07486479 2026-03-20

Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AML

204 enrolled

Phase 1/2 Not yet recruiting

Leukemia, Myeloid, Acute

NCT07486726 2026-03-20

Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia

112 enrolled

Leukemia, Myeloid, Acute

NCT07483476 2026-03-19

CIRCALL

205 enrolled

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07483749 2026-03-19

HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors

400 enrolled

Leukemia, Lymphoma, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07478991 2026-03-18

VENP-A-QUI

376 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Leukemia, Myeloid, Acute

NCT07476027 2026-03-17

Efficacy and Safety of CD7 CAR-T in Newly Diagnosed High-Risk T-LBL/ALL

10 enrolled

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT07476378 2026-03-17

Archonc-001

69 enrolled

Lymphoma, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT06930352 2026-03-13

Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy

70 enrolled

Leukemia, Myeloid, Acute

NCT07094750 2026-03-13

Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms

50 enrolled

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute

NCT07468916 2026-03-13

Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic Leukemia

MyeloidOther hematologic neoplasm

35 enrolled

Myeloproliferative Disorders, Thrombocytosis, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT07471841 2026-03-13

Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Received Venetoclax

25 enrolled

Phase 1/2 Not yet recruiting

Leukemia, Myeloid, Acute

NCT07372885 2026-03-11

GRACE

50 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT07463768 2026-03-11

MIVONU

60 enrolled

Leukemia, Myeloid, Acute

NCT07464951 2026-03-11

CART123

30 enrolled